Oral daily and intermittent ibandronate provide significant and sustained reductions in height loss in postmenopausal osteoporosis: Results from the bone study

被引：0

作者：

Delmas, PD

Hoiseth, A

Gilbride, J

Schimmer, RC

Chesnut, CH

机构：

[1] Univ Lyon 1, F-69365 Lyon, France

[2] INSERM, Res Unit 403, Lyon, France

[3] Sentrum Rontgeninst, Oslo, Norway

[4] F Hoffmann La Roche Ltd, Basel, Switzerland

[5] Univ Washington, Seattle, WA 98195 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S75 / S75

页数：1